Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Crystallization Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107400156B details a solvent-based resolution of Antcin K epimers, offering high purity and cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN108779133A reveals a novel crystallization-induced dynamic resolution for Tenofovir Alafenamide, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN104781243A details a novel chiral synthesis for ribonolactone intermediates. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN114163411A details a scalable crystallization resolution method for dihydromyricetin offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Advanced resolution process for IRS drug intermediates via diastereomeric salt crystallization. Enhances purity and reduces manufacturing costs for pharmaceutical supply chains.
Advanced crystallization-induced dynamic resolution for antiviral nucleotide analogs. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Eliminate chiral column costs with novel crystallization-based resolution. Achieve >99% ee and 76-78% yield for 6,6'-dihydroxy-5,5'-bisquinoline. Scale to 100MT/yr with NINGBO INNO PHARMCHEM's CDMO expertise.